These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15212841)

  • 1. Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.
    Hunter CL; Bimonte-Nelson HA; Nelson M; Eckman CB; Granholm AC
    Neurobiol Aging; 2004 Aug; 25(7):873-84. PubMed ID: 15212841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome.
    Granholm AC; Sanders L; Seo H; Lin L; Ford K; Isacson O
    Hippocampus; 2003; 13(8):905-14. PubMed ID: 14750653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice.
    Seo H; Isacson O
    Exp Neurol; 2005 Jun; 193(2):469-80. PubMed ID: 15869949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
    Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome.
    Granholm AC; Sanders LA; Crnic LS
    Exp Neurol; 2000 Feb; 161(2):647-63. PubMed ID: 10686084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral comparison of 4 and 6 month-old Ts65Dn mice: age-related impairments in working and reference memory.
    Hunter CL; Bimonte HA; Granholm AC
    Behav Brain Res; 2003 Jan; 138(2):121-31. PubMed ID: 12527443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.
    Hyde LA; Crnic LS
    Behav Neurosci; 2001 Dec; 115(6):1239-46. PubMed ID: 11770055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome.
    Granholm AC; Ford KA; Hyde LA; Bimonte HA; Hunter CL; Nelson M; Albeck D; Sanders LA; Mufson EJ; Crnic LS
    Physiol Behav; 2002 Nov; 77(2-3):371-85. PubMed ID: 12419414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
    Cheng XR; Zhou WX; Zhang YX
    Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural stem cells reduce hippocampal tau and reelin accumulation in aged Ts65Dn Down syndrome mice.
    Kern DS; Maclean KN; Jiang H; Synder EY; Sladek JR; Bjugstad KB
    Cell Transplant; 2011; 20(3):371-9. PubMed ID: 20875225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
    Stagni F; Giacomini A; Guidi S; Ciani E; Ragazzi E; Filonzi M; De Iasio R; Rimondini R; Bartesaghi R
    Neurobiol Dis; 2015 Feb; 74():204-18. PubMed ID: 25497735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome.
    Hunter CL; Isacson O; Nelson M; Bimonte-Nelson H; Seo H; Lin L; Ford K; Kindy MS; Granholm AC
    Neurosci Res; 2003 Apr; 45(4):437-45. PubMed ID: 12657457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline prevents cholinergic loss in a mouse model of Down's syndrome.
    Hunter CL; Bachman D; Granholm AC
    Ann Neurol; 2004 Nov; 56(5):675-88. PubMed ID: 15468085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome.
    Martínez-Cué C; Rueda N; García E; Davisson MT; Schmidt C; Flórez J
    Behav Brain Res; 2005 Sep; 163(2):174-85. PubMed ID: 15941601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome.
    Lockrow J; Boger H; Bimonte-Nelson H; Granholm AC
    Behav Brain Res; 2011 Aug; 221(2):610-22. PubMed ID: 20363261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
    Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
    Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model.
    Lockrow J; Boger H; Gerhardt G; Aston-Jones G; Bachman D; Granholm AC
    J Alzheimers Dis; 2011; 23(3):471-89. PubMed ID: 21098982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience-dependent reduction of soluble β-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome.
    Sansevero G; Begenisic T; Mainardi M; Sale A
    Exp Neurol; 2016 Sep; 283(Pt A):49-56. PubMed ID: 27288239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.